Update on Helicobacter pylori infection study and key points of «Maastricht-V» consensus conference (2016)

Aim of review. To review in brief the reports of the XXIX international working meeting of the European Helicobacter pylori (H. pylori) and Microbiota Study Group (Magdeburg, 2016) and to discuss the key points of «Maastricht V» consensus meeting, devoted to diagnosis and treatment of infection. Key...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Sheptulin, T. L. Lapina, V. O. Kaybysheva
Format: Article
Language:Russian
Published: Gastro LLC 2018-08-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/121
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860317702062080
author A. A. Sheptulin
T. L. Lapina
V. O. Kaybysheva
author_facet A. A. Sheptulin
T. L. Lapina
V. O. Kaybysheva
author_sort A. A. Sheptulin
collection DOAJ
description Aim of review. To review in brief the reports of the XXIX international working meeting of the European Helicobacter pylori (H. pylori) and Microbiota Study Group (Magdeburg, 2016) and to discuss the key points of «Maastricht V» consensus meeting, devoted to diagnosis and treatment of infection. Key points. Association of H. pylori to both gastroenterological and non-gastrointestinal diseases and optimization of eradication therapy modes were discussed at the consensus conference. The special attention was paid for decreasing of infection burden and the stomach cancer prevention. New eradication therapy modes were presented for the regions with high and low H. pylori resistance to clarithromycin and metronidazole. It was demonstrated that clarithromycin resistance in Russia significantly varies in different regions and highest efficacy was observed for bismuth-based (in particular - bismuth tripotassium dicitrate) eradication modes. Conclusion. The guidelines of «Maastricht V» consensus meeting provide significant improvement of treatment results in H.pylori-infected patients as well as decrease of the risk of associated diseases (first of all - the stomach cancer).
format Article
id doaj-art-f1b52d9ae1674b45a424b25bff8ed904
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2018-08-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-f1b52d9ae1674b45a424b25bff8ed9042025-02-10T16:14:29ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-01271354310.22416/1382-4376-2017-27-1-35-43121Update on Helicobacter pylori infection study and key points of «Maastricht-V» consensus conference (2016)A. A. Sheptulin0T. L. Lapina1V. O. Kaybysheva2State educational state-funded institution of higher professional education «Sechenov First Moscow state medical university»State educational state-funded institution of higher professional education «Sechenov First Moscow state medical university»Pirogov Russian National Research Medical UniversityAim of review. To review in brief the reports of the XXIX international working meeting of the European Helicobacter pylori (H. pylori) and Microbiota Study Group (Magdeburg, 2016) and to discuss the key points of «Maastricht V» consensus meeting, devoted to diagnosis and treatment of infection. Key points. Association of H. pylori to both gastroenterological and non-gastrointestinal diseases and optimization of eradication therapy modes were discussed at the consensus conference. The special attention was paid for decreasing of infection burden and the stomach cancer prevention. New eradication therapy modes were presented for the regions with high and low H. pylori resistance to clarithromycin and metronidazole. It was demonstrated that clarithromycin resistance in Russia significantly varies in different regions and highest efficacy was observed for bismuth-based (in particular - bismuth tripotassium dicitrate) eradication modes. Conclusion. The guidelines of «Maastricht V» consensus meeting provide significant improvement of treatment results in H.pylori-infected patients as well as decrease of the risk of associated diseases (first of all - the stomach cancer).https://www.gastro-j.ru/jour/article/view/121helicobacter pyloriдиагностикаэрадикацияпредупреждение рака желудкамикробиота желудка и кишечника
spellingShingle A. A. Sheptulin
T. L. Lapina
V. O. Kaybysheva
Update on Helicobacter pylori infection study and key points of «Maastricht-V» consensus conference (2016)
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
helicobacter pylori
диагностика
эрадикация
предупреждение рака желудка
микробиота желудка и кишечника
title Update on Helicobacter pylori infection study and key points of «Maastricht-V» consensus conference (2016)
title_full Update on Helicobacter pylori infection study and key points of «Maastricht-V» consensus conference (2016)
title_fullStr Update on Helicobacter pylori infection study and key points of «Maastricht-V» consensus conference (2016)
title_full_unstemmed Update on Helicobacter pylori infection study and key points of «Maastricht-V» consensus conference (2016)
title_short Update on Helicobacter pylori infection study and key points of «Maastricht-V» consensus conference (2016)
title_sort update on helicobacter pylori infection study and key points of maastricht v consensus conference 2016
topic helicobacter pylori
диагностика
эрадикация
предупреждение рака желудка
микробиота желудка и кишечника
url https://www.gastro-j.ru/jour/article/view/121
work_keys_str_mv AT aasheptulin updateonhelicobacterpyloriinfectionstudyandkeypointsofmaastrichtvconsensusconference2016
AT tllapina updateonhelicobacterpyloriinfectionstudyandkeypointsofmaastrichtvconsensusconference2016
AT vokaybysheva updateonhelicobacterpyloriinfectionstudyandkeypointsofmaastrichtvconsensusconference2016